Jeff Mirviss is Senior Vice President and President, Peripheral Interventions for Boston Scientific and a member of its Executive Committee. In that capacity, he is responsible for developing and bringing to market innovative solutions for treating patients with high blood pressure, vascular system blockages and cancer.
Mirviss has more than 23 years of experience in medical device and pharmaceutical general management, marketing and sales. He has held positions of increasing responsibility since 1997 at Boston Scientific.
In addition to his roles at Boston Scientific, Mirviss has worked for companies ranging in size from a pre-revenue venture-backed medical device startup to Dow 30 companies.
A resident of Plymouth, Minnesota, Mirviss holds a Bachelor’s degree from the University of Minnesota and an MBA from the University of St. Thomas.